Literature DB >> 9697818

Early lumen loss after treatment of in-stent restenosis: an intravascular ultrasound study.

A Shiran1, G S Mintz, R Waksman, R Mehran, A Abizaid, K M Kent, A D Pichard, L F Satler, J J Popma, M B Leon.   

Abstract

BACKGROUND: Mechanisms of recurrence after treatment of in-stent restenosis are unknown. METHODS AND
RESULTS: We prospectively performed quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS) in 37 lesions with Palmaz-Schatz stents enrolled in a study of intracoronary radiation for in-stent restenosis. Primary treatment was at the discretion of the operator: PTCA (n=8) or ablation+adjunct PTCA (n=29). Lesions were studied before intervention, immediately after primary intervention, and 42+/-8 minutes later. QCA measurements included minimal luminal diameter and diameter stenosis. Planar IVUS measurements included arterial, stent, lumen, and in-stent tissue areas. Stent, lumen, and in-stent tissue volumes were calculated by use of Simpson's rule. Compared with immediately after intervention, the delayed (42+/-8 minutes) minimal lumen area decreased by 20% (5.8+/-1.9 to 4.5+/-1.3 mm2, P<0.0001) and the lumen volume by 12% (58+/-41 to 52+/-37 mm3, P=0.0001). Ten lesions (27%) had a > or = 2.0-mm2 decrease in minimum lumen area. Lumen loss (1) resulted from increased tissue with the stent, (2) correlated with lesion length and preintervention in-stent tissue, and (3) was not seen angiographically.
CONCLUSIONS: There is significant tissue reintrusion shortly after catheter-based treatment of in-stent restenosis. This was greater in longer lesions and those with a larger in-stent tissue burden, was not reflected in the QCA measurements, and may contribute to recurrence.

Entities:  

Mesh:

Year:  1998        PMID: 9697818     DOI: 10.1161/01.cir.98.3.200

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

Review 1.  New recipes for in-stent restenosis: cut, grate, roast, or sandwich the neointima?

Authors:  C Di Mario; F Marsico; M Adamian; E Karvouni; R Albiero; A Colombo
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

2.  Impact of intima re-intrusion and expansion within 100 minutes on late lumen loss in percutaneous coronary intervention for diffuse in-stent restenosis.

Authors:  R Iijima; Y Ikari; T Tsunoda; M Nakamura; K Hara; T Yamaguchi
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

Review 3.  Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management.

Authors:  T M Schiele
Journal:  Z Kardiol       Date:  2005-11

4.  Intracoronary radiation therapy: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2001-12-01

Review 5.  Stent restenosis and the use of drug-eluting stents in patients with diabetes mellitus.

Authors:  Ian J Sarembock
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

6.  The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries.

Authors:  Aleksander Falkowski; Wojciech Poncyljusz; Grazyna Wilk; Małgorzata Szczerbo-Trojanowska
Journal:  Eur Radiol       Date:  2008-11-26       Impact factor: 5.315

Review 7.  Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients.

Authors:  Daniele Giacoppo; Giuseppe Gargiulo; Patrizia Aruta; Piera Capranzano; Corrado Tamburino; Davide Capodanno
Journal:  BMJ       Date:  2015-11-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.